Noninvasive Detection of Hemolysis with ETCOc Measurement in Neonates at Risk for Significant Hyperbilirubinemia.
Bilirubin
End-tidal carbon monoxide corrected for ambient carbon monoxide
Hemolysis
Hyperbilirubinemia
Neonate
Journal
Neonatology
ISSN: 1661-7819
Titre abrégé: Neonatology
Pays: Switzerland
ID NLM: 101286577
Informations de publication
Date de publication:
2020
2020
Historique:
received:
04
04
2020
accepted:
11
06
2020
pubmed:
8
9
2020
medline:
26
8
2021
entrez:
7
9
2020
Statut:
ppublish
Résumé
Hemolytic hyperbilirubinemia due to blood group incompatibility or glucose-6-phosphate dehydrogenase deficiency (G6PD) is a common cause of significant hyperbilirubinemia. Hemolysis in a hyperbilirubinemic infant increases the risk of bilirubin neurotoxicity. A new portable device (CoSense) can rapidly detect breath end-tidal carbon monoxide corrected to ambient carbon monoxide (ETCOc). ETCOc levels are surrogate markers of hemoglobin breakdown and bilirubin production. The aim was to evaluate the association between ETCOc values and hemolysis and its relevance in neonates at risk for significant hyperbilirubinemia. A prospective study was conducted among newborn infants born at more than 35 weeks and with a birth weight greater than 2,000 g with a G6PD deficiency, blood group incompatibility, or clinical jaundice needing phototherapy during the first 7 days of life. The recruited infants had their breath ETCOc measured twice, first on the day of recruitment and then again on the following day. Fifty infants completed this study. Their mean ETCOc was 1.61 (±0.56) ppm. There was a linear correlation (r = 0.89) between increasing ETCOc values and reticulocyte counts (RC). Sixteen newborns with ABO incompatibility had a significantly higher mean ETCOc of 1.98 ppm (±0.71) as compared to 1.43 (±0.38) ppm in the nonhemolytic hyperbilirubinemia (NHH) group (n = 25) (p = 0.002). This was suggestive of hemolysis as shown by the significantly higher RC of 6.90% (±3.38) compared to 4.68 (±1.26) in the NHH group (p <0.005). Neonates with an ETCOc level ≥1.8 ppm had a higher RC, a lower hemoglobin level, higher serum bilirubin levels, and a rapid rise in serum bilirubin and needed a longer duration of phototherapy. ETCOc values ≥1.8 ppm were suggestive of hemolysis (RC ≥6%), with a sensitivity of 90% and a specificity of 83%. Higher ETCOc values ≥1.8 ppm are suggestive of hemolysis and they are associated with significant hyperbilirubinemia.
Sections du résumé
BACKGROUND
Hemolytic hyperbilirubinemia due to blood group incompatibility or glucose-6-phosphate dehydrogenase deficiency (G6PD) is a common cause of significant hyperbilirubinemia. Hemolysis in a hyperbilirubinemic infant increases the risk of bilirubin neurotoxicity. A new portable device (CoSense) can rapidly detect breath end-tidal carbon monoxide corrected to ambient carbon monoxide (ETCOc). ETCOc levels are surrogate markers of hemoglobin breakdown and bilirubin production.
OBJECTIVE
The aim was to evaluate the association between ETCOc values and hemolysis and its relevance in neonates at risk for significant hyperbilirubinemia.
METHODS
A prospective study was conducted among newborn infants born at more than 35 weeks and with a birth weight greater than 2,000 g with a G6PD deficiency, blood group incompatibility, or clinical jaundice needing phototherapy during the first 7 days of life. The recruited infants had their breath ETCOc measured twice, first on the day of recruitment and then again on the following day.
RESULTS
Fifty infants completed this study. Their mean ETCOc was 1.61 (±0.56) ppm. There was a linear correlation (r = 0.89) between increasing ETCOc values and reticulocyte counts (RC). Sixteen newborns with ABO incompatibility had a significantly higher mean ETCOc of 1.98 ppm (±0.71) as compared to 1.43 (±0.38) ppm in the nonhemolytic hyperbilirubinemia (NHH) group (n = 25) (p = 0.002). This was suggestive of hemolysis as shown by the significantly higher RC of 6.90% (±3.38) compared to 4.68 (±1.26) in the NHH group (p <0.005). Neonates with an ETCOc level ≥1.8 ppm had a higher RC, a lower hemoglobin level, higher serum bilirubin levels, and a rapid rise in serum bilirubin and needed a longer duration of phototherapy. ETCOc values ≥1.8 ppm were suggestive of hemolysis (RC ≥6%), with a sensitivity of 90% and a specificity of 83%.
CONCLUSION
Higher ETCOc values ≥1.8 ppm are suggestive of hemolysis and they are associated with significant hyperbilirubinemia.
Identifiants
pubmed: 32894848
pii: 000509405
doi: 10.1159/000509405
pmc: PMC7845425
doi:
Substances chimiques
Bilirubin
RFM9X3LJ49
Banques de données
ISRCTN
['ISRCTN80570289']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
612-618Informations de copyright
© 2020 S. Karger AG, Basel.
Références
Semin Perinatol. 2014 Nov;38(7):429-37
pubmed: 25284470
J Perinatol. 2014 Aug;34(8):616-9
pubmed: 24762414
Pediatrics. 2003 Dec;112(6 Pt 1):1333-7
pubmed: 14654606
Pediatrics. 2004 Jul;114(1):297-316
pubmed: 15231951
J Perinatol. 2002 Jul-Aug;22(5):341-7
pubmed: 12082466
J Clin Invest. 1964 Jun;43:1098-103
pubmed: 14171787
Pediatrics. 2006 Jul;118(1):276-9
pubmed: 16818575
Acta Paediatr. 2015 Jun;104(6):e279-82
pubmed: 25640053
J Clin Invest. 1971 Jan;50(1):1-8
pubmed: 5543875
J Lab Clin Med. 1982 Nov;100(5):745-55
pubmed: 7130831
J Pediatr. 1995 Nov;127(5):804-6
pubmed: 7472840
Trans Am Clin Climatol Assoc. 2000;111:61-75
pubmed: 10881332
Clin Chim Acta. 2006 Mar;365(1-2):177-82
pubmed: 16188248
Semin Perinatol. 2001 Apr;25(2):85-93
pubmed: 11339670
Pediatrics. 2001 Jul;108(1):31-9
pubmed: 11433051
Acta Paediatr. 2016 May;105(5):e189-94
pubmed: 26802319
Clin Chem. 1994 Oct;40(10):1934-9
pubmed: 7923775
Pediatr Res. 2007 Jun;61(6):727-31
pubmed: 17426648
Pediatrics. 2009 Mar;123(3):1045-50
pubmed: 19255038
Acta Paediatr. 1998 Apr;87(4):455-7
pubmed: 9628306